The Impact of Depressive Symptoms on Healthcare Costs in Late Life: Longitudinal Findings From the AgeMooDe Study
| Autor: | Jens-Oliver Bock, Birgitt Wiese, Michael Wagner, Siegfried Weyerer, Wolfgang Maier, Hanna Kaduszkiewicz, Hans-Helmut König, Anne Stark, André Hajek, Janine Stein, Steffi G. Riedel-Heller, Jochen Werle, Lilia Moor |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Mental Health Services
Male medicine.medical_specialty Total cost Psychological intervention Affect (psychology) 03 medical and health sciences Nursing care 0302 clinical medicine Germany Surveys and Questionnaires Health care statistics & numerical data [Health Care Costs] medicine Humans 030212 general & internal medicine ddc:610 drug therapy [Depression] Longitudinal Studies Prospective Studies Psychiatry Depression (differential diagnoses) Aged Aged 80 and over Psychiatric Status Rating Scales business.industry Depression Health Care Costs 030227 psychiatry Psychiatry and Mental health economics [Depression] Regression Analysis Geriatric Depression Scale Female Geriatrics and Gerontology business statistics & numerical data [Mental Health Services] Cohort study |
| Zdroj: | American journal of geriatric psychiatry 25(2), 131-141 (2017). doi:10.1016/j.jagp.2016.10.011 |
| DOI: | 10.1016/j.jagp.2016.10.011 |
| Popis: | Objective To examine whether depressive symptoms affect healthcare costs in old age longitudinally. Design Multicenter prospective observational cohort study (two waves with n t1 = 1,195 and n t2 = 951) in Germany. Setting Community. Participants Participants aged 75 years and older recruited via general practitioners. Measurements Depressive symptoms were assessed by the Geriatric Depression Scale (GDS). The health-related resource use was measured retrospectively from a societal perspective based on a questionnaire, covering outpatient services, inpatient treatment, pharmaceuticals, as well as formal and informal nursing care. Hybrid regression models were used to determine the between- and within-effect of depressive symptoms on healthcare costs, adjusting for important covariates. Results Six-month total cost increased from €3,090 (t1) to €3,748 (t2). The hybrid random effects models showed that individuals with more depressive symptoms had higher healthcare costs compared with individuals with less depressive symptoms (between-effect). Moreover, an intra-individual increase in depressive symptoms increased healthcare costs by €539.60 (within-effect) per symptom on GDS. Conclusions Our findings emphasize the economic importance of depressive symptoms in old age. Appropriate interventions to treat depressive symptoms in old age might also be a promising strategy to reduce healthcare costs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|